Key Cell & Gene Therapy Manufacturing Services Market Players:
- Boehringer Ingelheim International GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bluebird Bio, Inc.
- Catalent, Inc.
- Charles River Laboratories International, Inc.
- Merck KGaA
- Miltenyi Bioindustry (Miltenyi Biotec)
- Samsung Biologics
- Thermo Fisher Scientific Inc
- WuXi AppTec Co., Ltd.
One of the key strategies adopted by the companies in the cell & gene therapy manufacturing services market is investing in capacity expansion. This is majorly done through building new facilities or upgrading existing ones to accommodate high-demand gene and cell therapy projects. In January 2023, FUJIFILM Irvine Scientific, Inc. launched the BalanCD HEK293 Viral Feed, which is intended to enhance AAV production for gene therapy applications and viral vector-based vaccines. These launches, in addition to other strategic activities, including geographical expansion, and partnerships between firms are projected to influence positive significant market activities, maintaining healthy competition between the players. Some of the prominent players are:
